NSE · CHEMCRUX
Chemcrux Enterprises Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹22 Cr with net profit ₹1 Cr — a 6.24% net margin, versus 4.51% the period before.
Shareholding
As of 2026-06-30
- Promoter72.92%
- Public27.08%
21,351 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.12× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #112 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹2,01,702 Cr | 101.29 | 32.13 | 26.72% | 17.54% |
| Pidilite Industries Ltd. | ₹1,59,492 Cr | 60.22 | 14.72 | 22.61% | 17.2% |
| SRF Ltd. | ₹73,585 Cr | 32.84 | 5.24 | 13.07% | 13.01% |
| Linde India Limited | ₹53,111 Cr | 97.2 | 12.45 | 12.87% | 20.59% |
| Gujarat Fluorochemicals Ltd. | ₹52,434 Cr | 84.89 | 6.71 | 7.13% | 11.41% |
| Navin Fluorine International Ltd. | ₹43,841 Cr | 55.13 | 11.03 | 16.69% | 21.73% |
| Godrej Industries Ltd. | ₹37,956 Cr | 31.02 | 3.4 | 11.1% | 5.06% |
| Himadri Speciality Chem Limited | ₹33,549 Cr | 41.98 | 7.13 | 15.96% | 16.07% |
| Aether Industries Limited | ₹22,228 Cr | 92.63 | 9.05 | 8.94% | 19.11% |
| Deepak Nitrite Ltd. | ₹21,656 Cr | 27.34 | 3.71 | 9.43% | 9.13% |
| Chemcrux Enterprises Ltd.(this company) | ₹122 Cr | 29.43 | 1.59 | 4.85% | 4.82% |
AI analysis
AI-generated · google/gemini-2.5-flashChemcrux Enterprises Limited is listed on the Indian markets with a market capitalization of Rs 131 Cr. The company has a PE ratio of 35.12 and an EPS of 2.52. Its book value stands at 51.89 with a dividend yield of 1.12%.
Positives
- +The profit margin is high at 462.55%.
- +Return on Equity (ROE) is significantly high at 485.46%.
- +Promoter holding is 72.9249%, indicating a strong commitment from the management.
- +Promoter pledging is 0%, indicating no shares are pledged by the promoters.
Negatives
- −The company is currently under LT-ASM Stage 1 surveillance.
- −The company's quarterly revenue has shown fluctuations, with a dip from Rs 22.11 Cr in Dec 2025 to Rs 16.5 Cr in Jun 2025.
- −Quarterly net profit decreased from Rs 1.58 Cr in Dec 2025 to Rs 0.09 Cr in Jun 2025.
- −Revenue growth information is not provided.
- −The number of shareholders increased from 113 in Sep 2017 to 21351 in Jun 2026.
Financial performance
In the financial year ending March 2025, Chemcrux Enterprises Limited reported revenue of Rs 71.4973 Cr, with a net profit of Rs 3.9131 Cr and an EBITDA of Rs 7.5109 Cr. For the quarter ending March 2026, the company recorded a revenue of Rs 24.28 Cr, net profit of Rs 1.85 Cr, and EBITDA of Rs 3.37 Cr.
Profitability & returns
The company's Return on Equity (ROE) is 485.46%, and its Return on Capital Employed (ROCE) is 7.5787%. The profit margin for the company was 462.55%. In the latest available annual results, the EPS was 2.64 as of March 2025.
Balance sheet
Chemcrux Enterprises Limited has a debt-to-equity ratio of 0.47, indicating its reliance on debt financing relative to equity. The book value per share is Rs 51.89.
Ownership & pledges
As of June 30, 2026, promoters held 72.9249% of the company's shares. Public shareholding was 27.0751%, with no reported FII or DII holdings. There are no pledged shares by the promoters.
Regulatory & surveillance
Chemcrux Enterprises Limited is currently under LT-ASM (Long Term Additional Surveillance Measure) Stage 1, indicating enhanced monitoring by regulatory bodies.
Data as of — price: 2026-09-11 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.